| Publication |
Data |
|
Fish |
Anatomy
|
|
Masud et al., 2025
|
Fig. 5
|
|
WT + MO4-tafazzin
|
|
|
Oyarbide et al., 2025
|
Fig. 1
|
|
tafazzinlri113/lri113
|
|
|
|
Fig. 2
|
|
tafazzinlri113/lri113
|
|
|
|
Fig. 3
|
|
tafazzinlri113/lri113
|
- whole organism 3-methylglutaconic acid increased amount, abnormal
- whole organism ATP decreased amount, abnormal
- whole organism cholesterol decreased amount, abnormal
- whole organism fatty acid 20:0 increased amount, abnormal
- whole organism fatty acid 20:1 increased amount, abnormal
- whole organism lysophosphatidylcholine increased amount, abnormal
- whole organism monolysocardiolipin(2-) increased amount, abnormal
- whole organism O-octadecanoyl-L-carnitine increased amount, abnormal
- whole organism O-tetradecanoyl-L-carnitine increased amount, abnormal
- whole organism phosphatidylcholine increased amount, abnormal
|
|
|
Fig. 4
|
|
tafazzinlri113/lri113
|
|
|
|
Fig. 6
|
|
tafazzinlri113/lri113
|
|
|
|
Fig. 7
|
|
tafazzinlri113/lri113
|
- head kidney atf4b expression increased amount, abnormal
- head kidney atf6 expression increased amount, abnormal
- head kidney baxa expression increased amount, abnormal
- head kidney bbc3 expression increased amount, abnormal
- head kidney cdkn1a expression increased amount, abnormal
- head kidney cebpa expression increased amount, abnormal
- head kidney cebpd expression increased amount, abnormal
- head kidney ddit3 expression increased amount, abnormal
- head kidney hadhab expression increased amount, abnormal
- head kidney il6 expression increased amount, abnormal
- head kidney tafazzin expression decreased amount, abnormal
- head kidney monolysocardiolipin(2-) increased amount, abnormal
- heart hadhaa expression increased amount, abnormal
- heart hadhab expression increased amount, abnormal
- heart il6 expression increased amount, abnormal
- heart lclat1 expression increased amount, abnormal
- heart tafazzin expression decreased amount, abnormal
- heart tp53 expression increased amount, abnormal
- heart monolysocardiolipin(2-) increased amount, abnormal
|
|
|
text only
|
|
tafazzinlri113/lri113
|
|
|
Burkhalter et al., 2019
|
Fig. 6
|
|
WT + MO4-tafazzin
|
|
|
|
Fig. S13
|
|
WT + MO4-tafazzin
|
|
|
Khuchua et al., 2006
|
Fig. 3
|
|
WT + MO1-tafazzin
, 
WT + MO2-tafazzin
, 
WT + MO3-tafazzin
|
- blood circulation arrested, abnormal
- embryo development arrested, abnormal
- eye physical object quality, abnormal
- heart contraction decreased rate, abnormal
- heart linear, abnormal
- heart looping arrested, abnormal
- heart morphology, abnormal
- pericardium edematous, abnormal
- post-vent region decreased length, abnormal
- post-vent region increased curvature, abnormal
- post-vent region morphology, abnormal
- whole organism lacks all parts of type head, abnormal
- whole organism lacks all parts of type heart, abnormal
- whole organism viability, abnormal
|